Cargando…

Correction: Community-driven development of a modified progression-free survival ratio for precision oncology

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046392/ https://www.ncbi.nlm.nih.gov/pubmed/33551065 http://dx.doi.org/10.1136/esmoopen-2019-000583corr1

Ejemplares similares

Community-driven development of a modified progression-free survival ratio for precision oncology
por: Mock, Andreas, et al.
Publicado: (2019)

Correction to: Precision medicine in pediatric oncology
por: Burdach, Stefan E. G., et al.
Publicado: (2022)

Correction to: Innovative radiation oncology Together—Precise, Personalized, Human
por: Krug, David, et al.
Publicado: (2021)

Correction to: Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021)

Correction to: Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology
por: Sesé, Borja, et al.
Publicado: (2021)

Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
por: Chitrangi, Swati, et al.
Publicado: (2023)

Genomics driven precision oncology in advanced biliary tract cancer improves survival
por: Kumar-Sinha, Chandan, et al.
Publicado: (2023)

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
por: Wang, Zi-Xian, et al.
Publicado: (2021)

Correction: Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

Correction: Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

Correction to: Working Towards the Development and Implementation of Precision Mental Healthcare: An Example
por: Lutz, Wolfgang, et al.
Publicado: (2021)

Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
por: Tamborero, David, et al.
Publicado: (2022)

Author Correction: Microbial community dynamics and coexistence in a sulfide-driven phototrophic bloom
por: Bhatnagar, Srijak, et al.
Publicado: (2023)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: Preparing for the incoming wave of biosimilars in oncology
Publicado: (2018)

Model‐based prediction of progression‐free survival for combination therapies in oncology
por: Baaz, Marcus, et al.
Publicado: (2023)

Correction: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia
por: Sun, Haibo, et al.
Publicado: (2017)

Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
por: Remon, J., et al.
Publicado: (2020)

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
por: Sjöholm, Therese, et al.
Publicado: (2023)

Special Issue “Precision Oncology in Melanoma Progression”
por: D’Aguanno, Simona
Publicado: (2021)

Correction: Modified cardiovascular SOFA score in sepsis: development and internal and external validation
por: Lee, Hui Jai, et al.
Publicado: (2022)

Correction to “Long‐term community shifts driven by local extinction of an iconic foundation species following an extreme marine heatwave”
Publicado: (2023)

Correction to “Changes in nitrogen and phosphorus availability driven by secondary succession in temperate forests shape soil fungal communities and function”
Publicado: (2023)

Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology
por: Yee, Nelson S.
Publicado: (2020)

Correction: Oncological care organisation during COVID-19 outbreak
Publicado: (2020)

Correction to: Dose Finding in Oncology: What is Impeding Coming of Age?
por: Mayawala, Kapil, et al.
Publicado: (2022)

Correction: Precision information extraction for rare disease epidemiology at scale
por: Kariampuzha, William Z., et al.
Publicado: (2023)

Correction: Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2019)

Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
por: Zhou, Shijie, et al.
Publicado: (2018)

Correction: The environmental consequences of climate-driven agricultural frontiers
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i4n634vuhh5hdudoo4i8knlrba